Arca
Skip to content
Tools
Tools

PEMRYDI RTU (pemetrexed injection)

Recall D-0764-2026, part of FDA recall event 99530. See Shilpa Medicare's company page.

Shilpa Medicare Limited started this Class II drug recall on Jul 29, 2026 (voluntary: firm initiated); FDA lists it as ongoing.

  • Classification: Class II
  • Started: Jul 29, 2026
  • Status: Ongoing
  • Products in this event: 2

Why It Was Recalled

Class II

Discolored solution. The firm has received market complaints reporting green to dark green discoloration in certain vials

Record

Product
PEMRYDI RTU (pemetrexed injection), 100 mg/10 mL (10 mg/mL), Single-dose vial, Rx only, Manufactured by: Zydus Lifesciences Limited, Ahmedabad, India; Distributed by: Amneal Pharmaceuticals LC, Bridgewater, NY 08807. NDC: 70121-2453-1
Quantity
18,434 10mL vials
Lots and codes
Lot: P400172; Lot PA00050A, Exp 09/30/2027
Distribution
Nationwide in the USA.
Recalling firm
Shilpa Medicare Limited, Jadcherla, Mahabubnagar District, India
How the firm notified
Letter
FDA classified
Aug 14, 2026

Other Products in This Recall

Recall event 99530

Shilpa Medicare Limited's Other Recalls

Newest first, one product per recall event; search them all

FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA drug enforcement reports

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.